Exact Sciences
EXAS
#1149
Rank
A$29.08 B
Marketcap
A$153.28
Share price
0.24%
Change (1 day)
60.65%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): A-$8.54

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is A-$8.02. In 2024 the company made an earnings per share (EPS) of A-$8.39.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$8.541.76%
2024A-$8.39
2022A-$5.332.31%
2021A-$5.21-38.54%
2020A-$8.48692.96%
2019A-$1.07-50.69%
2018A-$2.1744%
2017A-$1.51-39.39%
2016A-$2.49-2.94%
2015A-$2.5637.1%
2014A-$1.8779.71%
2013A-$1.04-21.59%
2012A-$1.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Myriad Genetics
MYGN
A-$6.52-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$0.51-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
A$0.59-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A-$76.69 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$5.58-169.66%๐Ÿ‡ซ๐Ÿ‡ท France